# ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers

> **NCT07314268** · — · RECRUITING · sponsor: **University of Sao Paulo General Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Wild-type ATTR Amyloidosis
- Amyloidosis Cardiac
- Amyloidosis, Hereditary
- Amyloidosis Transthyretin

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07314268
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-18
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314268, "ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07314268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*